iShares Biotechnology ETF $IBB Stock Purchased by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. raised its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 42.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 32,080 shares of the financial services provider’s stock after buying an additional 9,552 shares during the period. Oppenheimer & Co. Inc.’s holdings in iShares Biotechnology ETF were worth $6,754,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of IBB. IFP Advisors Inc boosted its holdings in shares of iShares Biotechnology ETF by 39.3% in the 2nd quarter. IFP Advisors Inc now owns 49,988 shares of the financial services provider’s stock worth $9,507,000 after acquiring an additional 14,115 shares in the last quarter. Security National Bank of Sioux City Iowa IA increased its holdings in iShares Biotechnology ETF by 31.8% during the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 12,187 shares of the financial services provider’s stock valued at $2,318,000 after purchasing an additional 2,939 shares in the last quarter. Kestra Advisory Services LLC raised its position in iShares Biotechnology ETF by 12.2% in the 1st quarter. Kestra Advisory Services LLC now owns 47,461 shares of the financial services provider’s stock valued at $8,014,000 after purchasing an additional 5,155 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in iShares Biotechnology ETF by 64.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 101,838 shares of the financial services provider’s stock valued at $19,369,000 after purchasing an additional 39,760 shares during the last quarter. Finally, Navellier & Associates Inc. bought a new position in iShares Biotechnology ETF in the 2nd quarter valued at $531,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $216.35 on Thursday. The business’s fifty day moving average is $208.27 and its two-hundred day moving average is $184.36. iShares Biotechnology ETF has a 52 week low of $154.62 and a 52 week high of $217.12.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were paid a $0.0112 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.0%. This is a drop from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. The ex-dividend date was Tuesday, September 15th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.